Dr. Reddys Laboratories Ltd.

BSE: 500124 | NSE: DRREDDY
Mid Cap | Pharmaceuticals & Drugs
1387.00
7.00 (0.51%)
< Home < Back

Dr Reddy's Laboratories' Srikakulam unit gets USFDA’s VAI classification

Date: 29-10-2026

The United States Food & Drug Administration (USFDA) has classified the inspection outcome of Dr Reddy's Laboratories’ FTO-SEZ Process Unit-02 in Srikakulam, Andhra Pradesh, as 'Voluntary Action Indicated' (VAI) and officially closed the inspection. The USFDA had conducted Pre-Approval Inspection (PAI) and Good Manufacturing Practices (GMP) inspection at the company’s said unit in Andhra Pradesh.

According to the US health regulator's guidelines, a VAI classification means that objectionable conditions or practices were observed during the inspection, but the agency is not recommending or taking any regulatory or administrative action.

Dr. Reddy's Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.